News & Training
Staburo news about trainings, events and more
Staburo supports research on the impact of coronavirus disease on methodological aspects of ongoing clinical trials
Staburo supports research on the impact of coronavirus disease on methodological aspects of ongoing clinical trials On behalf of Staburo, Josef Höfler and our former colleague Nicole Krämer submitted comments on the EMA’s draft guidance on “Points to consider on...
Post event: Anything new for oncology?
Post event: Anything new for oncology? Lately, Basel Biometric Section and EFSPI organized a webinar "Estimands addendum is final: Anything new for oncology?". You can find the program, the slides, a recording of the entire event, and a document that answers questions...
Staburo @ Joint EFSPI / BBS Webinar: Estimands addendum is final: Anything new for oncology?
Staburo @ Joint EFSPI / BBS Webinar: Estimands addendum is final: Anything new for oncology? We are very proud that Staburo's Managing Director Dr. Hannes Buchner will be a speaker and will talk about "Treatment switching: challenges, estimands, and estimators". All...
How to Avoid Overfitting, Precision Medicine in Action & Tumour Growth Modelling – three PSI contributions
Staburo's 2020 PSI contributions in webinar format on 26 May (15:00 – 17:15 CET) Since the 2020 PSI conference will unfortunately not take place, we decided to share our PSI contributions in an online live webinar with our colleagues. Staburo biostatisticians Nicole...
Staburo supported evaluation of medical device which got FDA Emergency Use Authorization for COVID-19
Staburo supported evaluation of medical device which recently got FDA Emergency Use Authorization for COVID-19Staburo Managing Director Dr. Hannes Buchner and our team was involved in statistical consulting and performing data analysis in a trial for a medical device...
Staburo team home office workout
Staburo team stays healthy, positive and at home The Staburo team is entirely working from home, which works quite seamlessly thanks to a well prepared IT infrastructure and software tools. To keep a positive attitude during uncertain times, Staburo Managing Director...
Students from the University of Copenhagen visited Staburo
Students from the University of Copenhagen visited StaburoNine Master students from the University of Copenhagen visited Staburo as part of their Statistical Study Trip to Munich.After a welcome from our Managing Director Josef Höfler, the students learned more about...
Training @ Staburo: AMNOG and HTA
Training @ Staburo: AMNOG and HTAHow beneficial are new drugs? This question gained more and more importance, after the German authorities introduced the AMNOG law in 2011, to restructure the market and the reimbursement system. Since then, it is obligatory that every...
Staburo at the G-BA in Berlin
Staburo at the G-BA in BerlinJosef Höfler from Staburo participated as statistical expert in an advisory meeting at the institution of “Gemeinsamer Bundesausschuss” in Berlin, in the context of health technology assessment.The Federal Joint Committee (G-BA) is the...
You need support in data science?
Memberships and awards
